Wegovy causes diarrhea because its active ingredient, semaglutide, activates receptors throughout your digestive tract that slow down how quickly food moves through your stomach while also changing how your intestines handle fluid and digestion. These GI effects are among the most common side effects of the drug, though they tend to be worst during the first few months and improve as your body adjusts.
How Wegovy Disrupts Normal Digestion
Semaglutide mimics a hormone called GLP-1 that your gut naturally produces after eating. One of GLP-1’s jobs is to slow gastric emptying, meaning food stays in your stomach longer than it normally would. This is actually part of how Wegovy helps with weight loss: you feel full sooner and stay full longer. But it also means your entire digestive system has to recalibrate how it processes food.
When food lingers in the stomach and then moves through the intestines on an altered schedule, the balance of fluid absorption gets thrown off. Your intestines may not reabsorb water as efficiently, and the changes in motility can push contents through the lower GI tract faster than normal. The result, for many people, is loose stools or outright diarrhea. Greasy or high-fat foods make this worse because they already take longer to digest. When Wegovy slows things down further, the mismatch between what your stomach is doing and what your intestines expect can trigger cramping and urgency.
There’s also emerging evidence that GLP-1 drugs alter the composition of gut bacteria, though research on exactly how these microbiome shifts contribute to diarrhea in humans is still being studied.
When Diarrhea Typically Starts and How Long It Lasts
Most people who develop diarrhea notice it within hours to days of their first injection, or after a dose increase. This timing matters because Wegovy uses a gradual dose-escalation schedule, starting at 0.25 mg and working up to the full 2.4 mg dose over about 16 to 20 weeks. Each step up can re-trigger GI symptoms you thought you’d gotten past.
Clinical trial data confirms that GI side effects are most prevalent during the dose-escalation period. For the majority of people, symptoms are transient and tend to settle by around 20 weeks of use, once the body has adjusted to the medication’s effects on gastric emptying. In pooled data from three large weight-management trials, diarrhea severe enough to make someone stop taking Wegovy entirely occurred in only 0.7% of participants, compared to 0.1% on placebo. So while mild or moderate diarrhea is common, the kind that’s truly unbearable is relatively rare.
Foods That Make It Worse
Certain foods are more likely to trigger or worsen diarrhea while you’re on Wegovy. Fried foods and high-fat meals sit in your stomach longer because digestion is already slowed, creating a backlog that can lead to cramping, nausea, and loose stools further down the line. Sugary foods and drinks, including soda, candy, and pastries, can cause blood sugar shifts that compound the problem and independently trigger diarrhea.
If you’re in a rough patch, especially right after a dose increase, sticking to bland foods can help. Bananas, mashed sweet potatoes, eggs, and plain chicken breast are gentle options. Eating smaller meals more frequently throughout the day, rather than two or three large ones, gives your slowed stomach a better chance of keeping up. Eating slowly and stopping as soon as you feel full also reduces the odds of overwhelming your digestive system.
Dehydration Is the Real Risk
The diarrhea itself, while unpleasant, is usually manageable. The bigger concern is what happens when diarrhea combines with the nausea and vomiting that often accompany Wegovy, especially early on. That combination can lead to significant fluid loss. The FDA’s updated prescribing information specifically warns that dehydration from GI side effects has led to acute kidney injury in some patients, with a small number requiring dialysis. This is rare, but it’s serious enough that the label was updated in October 2025 to include a dedicated warning about severe gastrointestinal adverse reactions.
Signs of dehydration to watch for include dry mouth, dizziness, dark urine, and noticeably reduced urination. Staying ahead of fluid loss by drinking water consistently throughout the day, not just when you feel thirsty, is the simplest way to protect yourself. This is especially important during the first few months and whenever your dose increases.
When Diarrhea Signals Something More Serious
Ordinary Wegovy-related diarrhea is uncomfortable but not dangerous. It comes and goes, improves over weeks, and doesn’t involve severe pain. What you want to watch for is a pattern that looks different from typical adjustment symptoms.
Pancreatitis is a known, though uncommon, risk with GLP-1 drugs. The key difference is pain: pancreatitis causes sudden, severe upper abdominal pain that may radiate to your back, often accompanied by persistent vomiting that doesn’t respond to over-the-counter remedies, fever, or a rapid heartbeat. Mild stomach upset in the first one to three months is your body adapting to the drug. Significant, unrelenting abdominal pain is not part of normal adjustment.
Other red flags that go beyond routine diarrhea include vomiting blood or material that looks like coffee grounds, yellowing of the skin or eyes, light-colored stools paired with dark urine, or sudden unexplained weight loss beyond what you’d expect from the medication. If two or more of these symptoms appear together, that warrants prompt medical attention rather than waiting to see if things improve on their own.
Severe GI Reactions by the Numbers
In clinical trials, 4.1% of adults taking Wegovy injections experienced severe gastrointestinal adverse reactions, compared to 0.9% on placebo. That means about 1 in 25 people had GI symptoms bad enough to be classified as severe. The vast majority of participants had milder symptoms that resolved without stopping the medication. Wegovy is not recommended for people with severe gastroparesis, a condition where the stomach already empties abnormally slowly, since the drug’s mechanism would compound that problem significantly.